Back to search

Article

Mechanism of dual pharmacological correction and potentiation of human CFTR

2022-10-11

Abstract excerpt

<h4>ABSTRACT</h4> Cystic fibrosis (CF) is caused by mutations in a chloride channel called the human Cystic Fibrosis Transmembrane Conductance Regulator (hCFTR). We used cryo-EM global conformational ensemble reconstruction to characterize the mechanism by which the breakthrough drug VX445 (Elexacaftor) simultaneously corrects both protein-folding and channel-gating defects caused by CF mutations. VX445 drives hC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
24ebe7b4-1a59-5789-acf3-9b8622f4d981
DOI
10.1101/2022.10.10.510913
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mechanism of dual pharmacological correction and potentiation of human CFTRDOI 10.1101/2022.10.10.510913
Select a neighboring publication to make it the new centre.